Astria Therapeutics, Inc. (ATXS)
13.00
+0.08
(+0.58%)
USD |
NASDAQ |
Dec 08, 16:00
13.00
0.00 (0.00%)
After-Hours: 20:00
Astria Therapeutics Shareholders Equity (Quarterly): 233.25M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | -387.89M |
| Hologic, Inc. | 5.048B |
| Johnson & Johnson | 79.28B |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 271.87M |
| Total Liabilities (Quarterly) | 38.61M |
| Debt to Equity Ratio | 0.0191 |
| Current Ratio | 10.78 |
| Net Debt Paydown Yield | 0.06% |